Novel computational and drug design strategies for the inhibition of human T-cell leukemia virus 1-associated lymphoma by Astilbin derivatives

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Bangham, C. R., & Matsuoka, M. (2017). Human T-cell leukaemia virus type 1: Parasitism and pathogenesis. Philosophical Transactions of the Royal Society B: Biological Sciences, 372(1732), 20160272. https://doi.org/10.1098/rstb.2016.0272
   PubMed Web of Science ®Google Scholar
• Chen, X., Li, H., Tian, L., Li, Q., Luo, J., & Zhang, Y. J. (2020). Analysis of the physicochemical properties of acaricides based on Lipinski’s rule of five. Journal of Computational Biology, 27(9), 1397–1406.
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. J. S. R (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7(1), 42717.
   Google Scholar
• Dallakyan, S. (2015). Small-molecule library screening by docking with PyRx. Chemical biology: methods and protocols,243–250.
   Google Scholar
• Debnath, B., & Ganguly, S. (2016). Synthesis, biological evaluation, in silico docking, and virtual ADME studies of 2-[2-Oxo-3-(arylimino) indolin-1-yl]-N-arylacetamides as potent anti-breast cancer agents. Monatshefte Für Chemie - Chemical Monthly, 147(3), 565–574. https://doi.org/10.1007/s00706-015-1566-9
   Google Scholar
• Demontis, M. A., Hilburn, S., & Taylor, G. P. (2013). Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases. AIDS Research and Human Retroviruses, 29(2), 359–364. https://doi.org/10.1089/AID.2012.0132
   PubMed Web of Science ®Google Scholar
• Frisch, M. J., Pople, J. A., & Binkley, J. S. (1984). Self‐consistent molecular orbital methods 25. Supplementary functions for Gaussian basis sets. The Journal of Chemical Physics, 80(7), 3265–3269. https://doi.org/10.1063/1.447079
   Web of Science ®Google Scholar
• Gece, G. (2008). The use of quantum chemical methods in corrosion inhibitor studies. Corrosion Science, 50(11), 2981–2992. https://doi.org/10.1016/j.corsci.2008.08.043
   Web of Science ®Google Scholar
• Ishitsuka, K., & Tamura, K. (2014). Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. The Lancet. Oncology, 15(11), e517–e526. https://doi.org/10.1016/S1470-2045(14)70202-5
   PubMed Web of Science ®Google Scholar
• Jaidhan, B., Rao, P. S., & Apparao, A. (2014). Energy minimization and conformation analysis of molecules using steepest descent method. International Journal of Computer Science and Information Technologies, 5, 3525–3528.
   Google Scholar
• Khorasanizadeh, S., Campos-Olivas, R., Clark, C. A., & Summers, M. F. (1999). Sequence-specific 1H, 13C and 15N chemical shift assignment and secondary structure of the HTLV-I capsid protein. Journal of Biomolecular NMR, 14(2), 199–200.
   PubMed Web of Science ®Google Scholar
• Kim, S., Lee, J., Jo, S., Brooks, C. L., III, Lee, H. S., & Im, W. (2017). CHARMM‐GUI ligand reader and modeler for CHARMM force field generation of small molecules. Wiley Online Library.
   Google Scholar
• Krishnan, S., Ramsden, D., Ferguson, D., Stahl, S. H., Wang, J., McGinnity, D. F., & Hariparsad, N. (2022). Challenges and opportunities for improved drug–drug interaction predictions for renal OCT2 and MATE1/2‐K transporters. Clinical Pharmacology and Therapeutics, 112(3), 562–572. https://doi.org/10.1002/cpt.2666
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1–3), 3–25. https://doi.org/10.1016/S0169-409X(96)00423-1
   Web of Science ®Google Scholar
• Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., & Yao, X. (2018). Molecular dynamics simulations and novel drug discovery. Expert Opinion on Drug Discovery, 13(1), 23–37. https://doi.org/10.1080/17460441.2018.1403419
   PubMed Web of Science ®Google Scholar
• March-Vila, E., Pinzi, L., Sturm, N., Tinivella, A., Engkvist, O., Chen, H., & Rastelli, G. (2017). On the integration of in silico drug design methods for drug repurposing. Frontiers in Pharmacology, 8, 298. https://doi.org/10.3389/fphar.2017.00298
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., & Olson, A. J. (2008). Using autodock for ligand‐receptor docking. Current protocols in bioinformatics, 24(1), 8–14.
   Google Scholar
• Music, D., Geyer, R. W., & Schneider, J. M. (2016). Recent progress and new directions in density functional theory based design of hard coatings. Surface and Coatings Technology, 286, 178–190. https://doi.org/10.1016/j.surfcoat.2015.12.021
   Web of Science ®Google Scholar
• Ogu, C. C., & Maxa, J. L. (2000). Drug interactions due to cytochrome P450. Proceedings (Baylor University. Medical Center), 13(4), 421–423. https://doi.org/10.1080/08998280.2000.11927719
   PubMedGoogle Scholar
• Paramashivam, S. K., Elayaperumal, K., Natarajan, B. B., Ramamoorthy, M. D., Balasubramanian, S., & Dhiraviam, K. N. (2015). In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases. Bioinformation, 11(2), 73–84. https://doi.org/10.6026/97320630011073
   PubMed Web of Science ®Google Scholar
• Pearlman, D. A. (2005). Evaluating the molecular mechanics Poisson − Boltzmann surface area free energy method using a congeneric series of ligands to p38 MAP kinase. Journal of Medicinal Chemistry, 48(24), 7796–7807. https://doi.org/10.1021/jm050306m
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2021). UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Science, 30(1), 70–82. https://doi.org/10.1002/pro.3943
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Qu, Z., & Xiao, G. (2011). Human T-cell lymphotropic virus: A model of NF-κB-associated tumorigenesis. Viruses, 3(6), 714–749. https://doi.org/10.3390/v3060714
   PubMed Web of Science ®Google Scholar
• Ramsay, R. R., Popovic-Nikolic, M. R., Nikolic, K., Uliassi, E., & Bolognesi, M. L. (2018). A perspective on multi-target drug discovery and design for complex diseases. Clinical and Translational Medicine, 7(1), 3. https://doi.org/10.1186/s40169-017-0181-2
   PubMed Web of Science ®Google Scholar
• Satoh, T., Li, M., Nguyen, J.-T., Kiso, Y., Gustchina, A., & Wlodawer, A. (2010). Crystal structures of inhibitor complexes of human T-cell leukemia virus (HTLV-1) protease. Journal of Molecular Biology, 401(4), 626–641. https://doi.org/10.1016/j.jmb.2010.06.052
   PubMed Web of Science ®Google Scholar
• Schlegel, H. B. (1982). Optimization of equilibrium geometries and transition structures. Journal of Computational Chemistry, 3(2), 214–218. https://doi.org/10.1002/jcc.540030212
   Web of Science ®Google Scholar
• Sharma, A., Gupta, S., Chauhan, S., Nair, A., & Sharma, P. (2020). Astilbin: A promising unexplored compound with multidimensional medicinal and health benefits. Pharmacological Research, 158, 104894. https://doi.org/10.1016/j.phrs.2020.104894
   PubMed Web of Science ®Google Scholar
• Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological Reviews, 66(1), 334–395. https://doi.org/10.1124/pr.112.007336
   PubMed Web of Science ®Google Scholar
• Sun, X.-H., Zhang, H., Fan, X.-P., & Wang, Z.-H. (2021). Astilbin protects against carbon tetrachloride-induced liver fibrosis in rats. Pharmacology, 106(5–6), 323–331. https://doi.org/10.1159/000514594
   PubMed Web of Science ®Google Scholar
• Testa, B., Crivori, P., Reist, M., & Carrupt, P.-A. (2000). The influence of lipophilicity on the pharmacokinetic behavior of drugs: Concepts and examples. Perspectives in Drug Discovery and Design, 19, 179–211.
   Google Scholar
• Tsukasaki, K., & Tobinai, K. (2014). Human T-cell lymphotropic virus type I–associated adult T-cell leukemia–lymphoma: New directions in clinical research. Clinical Cancer Research, 20(20), 5217–5225. https://doi.org/10.1158/1078-0432.CCR-14-0572
   PubMed Web of Science ®Google Scholar
• Van Prooyen, N., Gold, H., Andresen, V., Schwartz, O., Jones, K., Ruscetti, F., Lockett, S., Gudla, P., Venzon, D., & Franchini, G. (2010). Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proceedings of the National Academy of Sciences of the United States of America, 107(48), 20738–20743. https://doi.org/10.1073/pnas.1009635107
   PubMed Web of Science ®Google Scholar
• Wade, R. C., & Goodford, P. (1989). The role of hydrogen-bonds in drug binding. Progress in clinical and biological research, 289, 433–444.
   Google Scholar
• Yuan, S., Chan, H. S., & Hu, Z. J. (2017). Using PyMOL as a platform for computational drug design. Wiley Interdisciplinary Reviews: Computational Molecular Science, 7(2), e1298.
   Google Scholar
• Zhang, H.-B., Sun, L.-C., Zhi, L-D., Wen, Q.-K., Qi, Z.-W., Yan, S.-T., Li, W., & Zhang, G.-Q. (2017). Astilbin alleviates sepsis-induced acute lung injury by inhibiting the expression of macrophage inhibitory factor in rats. Archives of Pharmacal Research, 40(10), 1176–1185. https://doi.org/10.1007/s12272-016-0857-y
   PubMed Web of Science ®Google Scholar